Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Recruiting
×
Parkinson Disease 4, Autosomal Dominant Lewy Body
×
lenvatinib
×
Clear all
Filters
3
NCT04938817
2026-03-19
KEYNOTE-B98
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
110 enrolled
NCT05319730
2026-03-02
MK-3475-06B
Merck Sharp & Dohme LLC
Phase 1/2
Recruiting
230 enrolled